Mary Flowers, MD
Professor Emeritus
Clinical Research Division, Fred Hutch
Dr. Mary Flowers is a world-renowned expert in the study and treatment of chronic graft-vs-host disease, or cGVHD, a complication of transplantation in which the donated stem cells attack the recipient's healthy tissues. Dr. Flowers helps transplant survivors and their primary care physicians manage post-treatment complications as patients recover and resume their lives. In addition to her GVHD research, Dr. Flowers studies the effectiveness of using donated lymphocytes, a type of immune cell, to treat recurrent malignancies after transplantation with donated cells.
Other Appointments & Affiliations
Professor, Division of Hematology and Oncology, Department of Medicine, University of WashingtonProfessor, Division of Hematology and Oncology, Department of Medicine
University of Washington
Director at Large
American Society for Transplantation and Cellular Therapy (ASTCT) Executive Committee
Co-Chair
Brazil/Seattle Chronic GVHD Consortium
Co-Chair
Brazilian Society of BMT Chronic GVHD and Late Effects Working Group
Co-Chair
National Institute of Health (NIH) Chronic GVHD Diagnosis and Staging Working Group
Co-Chair
Center for International Blood & Marrow Transplant Research (CIBMTR) Working Committee for Late Effects and Quality of Life
Co-Chair
ASTCT and CIBMTR Scientific Organizing Committee
Education
MD, Centro de Ciencias da Saude da Universadiade Federal do Rio Grande do Norte, Natal, R.N., Brasil
Board Certified in Hematology, Pontifícia Universidade Catolica do Rio de Janeiro, Rio de Janeiro, R.J., Brazil
Clinical Expertise
Management of chronic GVHD and other late effects of hematopoietic cell transplantation.
Research Interests
Dr. Flowers’ clinical research has focused on long-term outcomes after hematopoietic cell transplantation (HCT), with particular attention to studies of chronic graft-versus-host disease (GVHD), quality of life and other late events. Her research has spanned the gamut from clinical trials to registry studies to cohort studies. She has been the principal investigator or co-investigator in several interventional clinical trials including multicenter randomized studies in chronic GVHD.